Amgen Inc. logo

Amgen Inc.

AMGN | NASDAQ
Chart Builder DCF Calculator
$393.16
+$7.51 (+1.95%)
At close: Sep 21, 2026, 4:00 PM ET
$392
-$1.16 (-0.30%)
After-hours: Sep 21, 2026, 7:59 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Revenue
36.74B 33.42B 28.19B 26.32B 25.98B 25.42B
Cost of Revenue
10.73B 12.86B 8.42B 6.41B 6.45B 6.16B
Gross Profit
26.01B 20.57B 19.78B 19.92B 19.53B 19.27B
Operating Income
10.68B 7.26B 7.9B 9.57B 7.64B 9.14B
Interest Income
n/a n/a n/a n/a n/a n/a
Pretax Income
8.98B 4.61B 7.86B 7.35B 6.7B 8.13B
Net Income
7.71B 4.09B 6.72B 6.55B 5.89B 7.26B
Selling & General & Admin
7.05B 7.1B 6.18B 5.41B 5.37B 5.73B
Research & Development
6.97B 5.96B 4.78B 4.43B 6.32B 4.21B
Other Expenses
1.31B 248M 879M 503M 194M 189M
Operating Expenses
15.34B 13.31B 11.84B 10.35B 11.89B 10.13B
Interest Expense
2.76B 3.16B 2.88B 1.41B 1.2B 1.26B
Selling & Marketing Expenses
n/a 987M n/a 841M 843M n/a
Cost & Expenses
26.07B 26.17B 20.29B 16.76B 18.34B 16.29B
Income Tax Expense
1.27B 519M 1.14B 794M 808M 869M
Shares Outstanding (Basic)
538M 541M 535M 538M 570M 586M
Shares Outstanding (Diluted)
542M 541M 538M 541M 573M 590M
EPS (Basic)
14.33 7.62 12.56 12.18 10.34 12.40
EPS (Diluted)
14.23 7.56 12.49 12.11 10.28 12.31
EBITDA
16.9B 13.36B 14.8B 12.17B 11.3B 13B
EBIT
11.73B 7.76B 10.73B 8.75B 7.9B 9.4B
Depreciation & Amortization
5.17B 5.59B 4.07B 3.42B 3.4B 3.6B

© 2026 bestshares.com. All rights reserved.